Package 50474-970-75

Brand: briviact

Generic: brivaracetam
NDC Package

Package Facts

Identity

Package NDC 50474-970-75
Digits Only 5047497075
Product NDC 50474-970
Product ID 50474-970_4c4ad01c-81d3-693d-e063-6294a90ab6c8
Description

10 VIAL, GLASS in 1 CARTON (50474-970-75) / 5 mL in 1 VIAL, GLASS (50474-970-63)

Marketing

Marketing Status
Marketed Since 2016-05-12
Brand briviact
Generic brivaracetam
Sample Package No

Linked Drug Pages (1)

Briviact ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "4c4ad01c-81d3-693d-e063-6294a90ab6c8", "openfda": {"nui": ["N0000192345"], "unii": ["U863JGG2IA"], "rxcui": ["1739749", "1739754", "1739761", "1739766", "1739768", "1739770", "1739772", "1739774", "1739776", "1739778", "1739780", "1739782", "1739785", "1739788"], "spl_set_id": ["3cf2f439-0e97-443e-8e33-25ecef616f6c"], "pharm_class_moa": ["Epoxide Hydrolase Inhibitors [MoA]"], "manufacturer_name": ["UCB, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, GLASS in 1 CARTON (50474-970-75)  / 5 mL in 1 VIAL, GLASS (50474-970-63)", "package_ndc": "50474-970-75", "marketing_start_date": "20160512"}], "brand_name": "Briviact", "product_id": "50474-970_4c4ad01c-81d3-693d-e063-6294a90ab6c8", "dosage_form": "INJECTION, SUSPENSION", "pharm_class": ["Epoxide Hydrolase Inhibitors [MoA]"], "product_ndc": "50474-970", "dea_schedule": "CV", "generic_name": "brivaracetam", "labeler_name": "UCB, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Briviact", "active_ingredients": [{"name": "BRIVARACETAM", "strength": "50 mg/5mL"}], "application_number": "NDA205837", "marketing_category": "NDA", "marketing_start_date": "20160512", "listing_expiration_date": "20271231"}